Registered entities
Palvella Therapeutics.
Reg. No. -Belgium
Innovation
7 patent families (4 granted) — focus: Human necessities; filing pace steady. Cited 1,576 times.
| Year | Filings |
|---|---|
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 1 |
Social engagement
Social engagement: 4.6K social following, 8 posts in the last 12 months — top quartile of its industry.
Investor mix
13 investors on record; lead investors include Petrichor, Samsara BioCapital, BVF Partners, Agent Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 31% |
| Private equity | 4 | 31% |
| Other / undisclosed | 5 | 38% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
27 Apr 2026 · Medical Science Liaisons, Field Marketing, Brand Marketing
Based on job postings tracked across public sources.
Recent activity
4 May 2026
Milestone
regulatory
13 Apr 2026
Leadership hire
Board of Directors